Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
0.9700
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT

Silence Therapeutics Statistics

Total Valuation

SLNCF has a market cap or net worth of 168.12 million. The enterprise value is 31.65 million.

Market Cap 168.12M
Enterprise Value 31.65M

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date May 15, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +24.69%
Shares Change (QoQ) +0.34%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 23.06M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 6.07
PB Ratio 1.49
P/TBV Ratio 1.64
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.44
EV / Sales 1.14
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -0.45

Financial Position

The company has a current ratio of 8.81, with a Debt / Equity ratio of 0.00.

Current Ratio 8.81
Quick Ratio 7.96
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF -0.00
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -106.17% and return on invested capital (ROIC) is -66.81%.

Return on Equity (ROE) -106.17%
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) -66.81%
Return on Capital Employed (ROCE) -43.50%
Revenue Per Employee 238,802
Profits Per Employee -616,612
Employee Count 116
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -87.88% in the last 52 weeks. The beta is 1.19, so SLNCF's price volatility has been higher than the market average.

Beta (5Y) 1.19
52-Week Price Change -87.88%
50-Day Moving Average 1.13
200-Day Moving Average 3.59
Relative Strength Index (RSI) 48.60
Average Volume (20 Days) 466

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SLNCF had revenue of 27.70 million and -71.53 million in losses. Loss per share was -1.52.

Revenue 27.70M
Gross Profit 18.64M
Operating Income -72.23M
Pretax Income -70.93M
Net Income -71.53M
EBITDA -71.65M
EBIT -72.23M
Loss Per Share -1.52
Full Income Statement

Balance Sheet

The company has 136.53 million in cash and 60,000 in debt, giving a net cash position of 136.47 million.

Cash & Cash Equivalents 136.53M
Total Debt 60,000
Net Cash 136.47M
Net Cash Per Share n/a
Equity (Book Value) 112.74M
Book Value Per Share 2.39
Working Capital 150.53M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -70.81 million and capital expenditures -215,000, giving a free cash flow of -71.02 million.

Operating Cash Flow -70.81M
Capital Expenditures -215,000
Free Cash Flow -71.02M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 67.28%, with operating and profit margins of -260.73% and -258.21%.

Gross Margin 67.28%
Operating Margin -260.73%
Pretax Margin -256.04%
Profit Margin -258.21%
EBITDA Margin -258.64%
EBIT Margin -260.73%
FCF Margin n/a

Dividends & Yields

SLNCF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -24.69%
Shareholder Yield -24.69%
Earnings Yield -42.55%
FCF Yield -42.24%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a